Seroprevalence of Brucella Antibodies in High-Risk Patients With Low Back Pain: A Case-Control Study

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
BrucellosisLow Back Pain
Interventions
DIAGNOSTIC_TEST

Brucella Antibody Testing (ELISA)

Serological testing for Brucella antibodies using the SERION ELISA classic Brucella IgG/IgM/IgA kit (Institut Virion\\Serion GmbH, Würzburg, Germany). The test detects Brucella-specific IgG, IgM, and IgA antibodies in serum samples to assess current or past exposure. All samples were processed and interpreted according to the manufacturer's instructions. This diagnostic intervention was used for both the low back pain group and the control group.

Trial Locations (2)

71515

Assiut University Hospital, Asyut

Assiut University, Asyut

All Listed Sponsors
lead

Elham Ahmed Hassan

OTHER

NCT07112677 - Seroprevalence of Brucella Antibodies in High-Risk Patients With Low Back Pain: A Case-Control Study | Biotech Hunter | Biotech Hunter